Previous Article | Next Article ![]()
Journal of Bacteriology, October 1999, p. 6552-6555, Vol. 181, No. 20
Lilly Research Laboratories, Eli Lilly and
Company, Lilly Corporate Center, Indianapolis, Indiana 46285
Received 14 June 1999/Accepted 3 August 1999
The effects of inactivation of the genes encoding
penicillin-binding protein 1a (PBP1a), PBP1b, and PBP2a in
Streptococcus pneumoniae were examined. Insertional mutants
did not exhibit detectable changes in growth rate or morphology,
although a pbp1a pbp1b double-disruption mutant grew more
slowly than its parent did. Attempts to generate a pbp1a
pbp2a double-disruption mutant failed. The pbp2a
mutants, but not the other mutants, were more sensitive to moenomycin,
a transglycosylase inhibitor. These observations suggest that
individually the pbp1a, pbp1b, and
pbp2a genes are dispensable but that either
pbp1a or pbp2a is required for growth in vitro.
These results also suggest that PBP2a is a functional transglycosylase
in S. pneumoniae.
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Gene Disruption Studies of Penicillin-Binding
Proteins 1a, 1b, and 2a in Streptococcus
pneumoniae
*
Corresponding author. Mailing address: Lilly Corporate
Center, Eli Lilly and Company, Infectious Diseases Research, Drop Code 0438, Indianapolis, IN 46285. Phone: (317) 277-1934. Fax: (317) 277-0778. E-mail: Hoskins_JoAnn{at}Lilly.com.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |